Among these targets, eukaryotic translation elongation factor 1 delta (EEF1D) has been reported to modulate proliferation and epithelial-mesenchymal transition in oral squamous cell carcinoma [30] and promote glioma proliferation, migration, and invasion through epithelial-mesenchymal transition and PI3K/Akt pathway [31]. This evidence concerns the gene EEF1D and central nervous system cancer.